Oxford Financial Statements From 2010 to 2024
| OCTHF Stock | USD 0 0.00 0.00% |
Check Oxford Cannabinoid financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oxford Cannabinoid's main balance sheet or income statement drivers, such as , as well as many indicators such as . Oxford financial statements analysis is a perfect complement when working with Oxford Cannabinoid Valuation or Volatility modules.
Oxford |
Oxford Cannabinoid Technologies Company Current Valuation Analysis
Oxford Cannabinoid's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Oxford Cannabinoid Current Valuation | (3.87 M) |
Most of Oxford Cannabinoid's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oxford Cannabinoid Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Oxford Cannabinoid Technologies has a Current Valuation of (3.87 Million). This is 100.03% lower than that of the Healthcare sector and 100.08% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 100.02% higher than that of the company.
Oxford Cannabinoid Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oxford Cannabinoid's current stock value. Our valuation model uses many indicators to compare Oxford Cannabinoid value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oxford Cannabinoid competition to find correlations between indicators driving Oxford Cannabinoid's intrinsic value. More Info.Oxford Cannabinoid Technologies is rated top company in current valuation category among its peers. It also is considered to be number one stock in shares outstanding category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oxford Cannabinoid's earnings, one of the primary drivers of an investment's value.About Oxford Cannabinoid Financial Statements
Oxford Cannabinoid stakeholders use historical fundamental indicators, such as Oxford Cannabinoid's revenue or net income, to determine how well the company is positioned to perform in the future. Although Oxford Cannabinoid investors may analyze each financial statement separately, they are all interrelated. For example, changes in Oxford Cannabinoid's assets and liabilities are reflected in the revenues and expenses on Oxford Cannabinoid's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Oxford Cannabinoid Technologies. Please read more on our technical analysis and fundamental analysis pages.
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom. Oxford Cannabinoid is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Oxford Pink Sheet
Oxford Cannabinoid financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford Cannabinoid security.